Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,064 | Dovepress* | 7,829+ | 1,123 | 8,952 | |
| PubMed Central* | 1,235 | 289 | 1,524 | ||
| Totals | 9,064 | 1,412 | 10,476 | ||
| *Since 1 November 2018 | |||||
View citations on PubMed and Google Scholar